Cite
HARVARD Citation
Howell, J. et al. (2017). On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study. Alimentary pharmacology & therapeutics. 45 (8), pp. 1146-1155. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Howell, J. et al. (2017). On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study. Alimentary pharmacology & therapeutics. 45 (8), pp. 1146-1155. [Online].